Cogent Biosciences, Inc. ( COGT) - Stock Earnings
COGT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
COGT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -102.5 million USD | — USD |
| 2026Q1 | -97.4 million USD | — USD |
| 2026Q2 | -96.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
COGT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -192.4 million USD | — USD |
| 2024 | -255.9 million USD | — USD |
| 2025 | -328.9 million USD | — USD |
| 2026 Est. | — | — |
COGT
Price: $28.50
52 week price:
Earnings Per Share: -2.19 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 528500
Ebitda: -29.7 millionMarket Capitalization: 5.3 billion